Can healthcare innovation strengthen Ireland's competitiveness?

A notable aspect of Budget 2027 is the Government's commitment to a more strategic approach to medicines and health technology access. Patient access and competitiveness are increasingly two sides of the same coin. A healthcare system that can evaluate, adopt and reimburse innovative medicines and technologies more effectively delivers better outcomes for patients while also sending a powerful signal to investors, innovators and multinational companies that Ireland is serious about innovation.

The new scaling fund for business and changes to the R&D regime also help. However, industry will now be looking for concrete actions that accelerate access pathways, improve reimbursement processes and create greater certainty around the adoption of innovation within the healthcare system. The real test will be translating that ambition into practical reforms that improve patient access while further strengthening Ireland's position as a leading global hub for medtech, life sciences and healthcare innovation.